Skip to main content
CTIS.
EU
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
EN — English
BG — Български
CS — Čeština
DA — Dansk
DE — Deutsch
EL — Ελληνικά
ES — Español
ET — Eesti
FI — Suomi
FR — Français
GA — Gaeilge
HR — Hrvatski
HU — Magyar
IT — Italiano
LT — Lietuvių
LV — Latviešu
MT — Malti
NL — Nederlands
PL — Polski
PT — Português
RO — Română
SK — Slovenčina
SL — Slovenščina
SV — Svenska
NO — Norsk
CTIS.
EU
✕
Conditions
IMPs
Countries
Sponsors
Sites
Trial Map
Safety
Transparency
Landscape
Notice
This is an independent non-profit initiative. We are not affiliated with the European Medicines Agency (EMA) or the official CTIS system. For the official EU Clinical Trials Information System, visit:
EMA Registry →
CTIS.eu
›
Drugs
› B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated, Influenza A Virus/Thailand/8/2022 (H3N2)-Like Strain (A/California/122/2022, San-022), Inactivated
B/Phuket/3073/2013-Like Virus (B/Phuket/3073/2013, Wild Type), Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26), Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated, Influenza A Virus/Thailand/8/2022 (H3N2)-Like Strain (A/California/122/2022, San-022), Inactivated
1 trials
1 recruiting
J
Anti-infectives
Filter these 1 trials by condition, phase, country and more.
Open in Search →
1
Registered trials
1
Recruiting
0
Completed trials
1
Sponsors
1
Countries
Phase II
Phase II:
1
Sponsors using this IMP
Zealand University Hospital
1
All trials
1 total
Intratumoral Flu Vaccine and Pembrolizumab in Colorectal Cancer
Recruiting
2023-503228-17-00
Phase II
1 country
Zealand University Hospital
Showing 1–1 of 1 trials
← All drugs A–Z